GeneDx Holdings Corp. (WGS)
90.27
+2.86
(+3.28%)
USD |
NASDAQ |
Aug 26, 16:00
91.31
+1.04
(+1.15%)
After-Hours: 18:19
GeneDx Holdings Debt to Equity Ratio : 0.6855 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6855 |
| March 31, 2026 | 0.6619 |
| December 31, 2025 | 0.3672 |
| September 30, 2025 | 0.3914 |
| June 30, 2025 | 0.4172 |
| March 31, 2025 | 0.4509 |
| December 31, 2024 | 0.4786 |
| September 30, 2024 | 0.5736 |
| June 30, 2024 | 0.6084 |
| March 31, 2024 | 0.5751 |
| December 31, 2023 | 0.5253 |
| September 30, 2023 | 0.2903 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.2544 |
| March 31, 2023 | 0.2293 |
| December 31, 2022 | 0.304 |
| September 30, 2022 | 0.1389 |
| June 30, 2022 | 0.1233 |
| March 31, 2022 | 0.2233 |
| December 31, 2021 | 0.0846 |
| September 30, 2021 | 0.0281 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 9.858 |
| September 30, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CS Diagnostics Corp. | 0.00 |
| Aibotics, Inc. | -0.2804 |
| GRAIL, Inc. | 0.0359 |
| Ayujoy Herbals Ltd. | -- |
| Twist Bioscience Corp. | 0.21 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 481.49M |
| Total Liabilities (Quarterly) | 237.26M |
| Shareholders Equity (Quarterly) | 244.22M |
| Current Ratio | 3.301 |
| Net Debt Paydown Yield | -0.50% |